Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Receivables (2016 - 2025)

Ultralife (ULBI) has 15 years of Receivables data on record, last reported at $30.9 million in Q3 2025.

  • For Q3 2025, Receivables rose 11.44% year-over-year to $30.9 million; the TTM value through Sep 2025 reached $30.9 million, up 11.44%, while the annual FY2024 figure was $29.4 million, 7.53% down from the prior year.
  • Receivables reached $30.9 million in Q3 2025 per ULBI's latest filing, down from $32.3 million in the prior quarter.
  • Across five years, Receivables topped out at $36.1 million in Q1 2025 and bottomed at $16.2 million in Q3 2021.
  • Average Receivables over 4 years is $27.8 million, with a median of $29.0 million recorded in 2023.
  • Peak YoY movement for Receivables: crashed 46.42% in 2021, then skyrocketed 44.21% in 2024.
  • A 4-year view of Receivables shows it stood at $16.2 million in 2021, then surged by 95.63% to $31.8 million in 2023, then fell by 7.53% to $29.4 million in 2024, then increased by 5.31% to $30.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $30.9 million in Q3 2025, $32.3 million in Q2 2025, and $36.1 million in Q1 2025.